No certain predictors for mutation status in a Danish cohort with familial hypercholesterolemia: A descriptive study

Clinical Biochemistry

Volumn 40, Issue 18, 2007, Pages 1347-1352

  Nybo, Mads ^a   Brusgaard, Klaus ^a   Hansen, Annebirthe Bo ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular disease; Familial hypercholesterolemia; Mutation status; Predictors; Risk factor

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; ROC CURVE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; COHORT STUDIES; DENMARK; FAMILY; FEMALE; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES;

EID: 36348954968     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.09.012     Document Type: Article

References (27)

1. Hobbs H.H., Russell D.W., Brown M.S., and Goldstein J.L. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 24 (1990) 133-170
2. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic Basis of Inherited Disease. 7th ed. (1995), McGraw-Hill, New York 1981-2030
3. Lombardi M.P., Redeker E.J., van Gent D.H., Smeele K.L., Weerdesteijn R., and Mannens M.M. Molecular genetic testing for familial hypercholesterolemia in the Netherlands: a stepwise screening strategy enhances the mutation detection rate. Genet Test 10 (2006) 77-84
4. Bhatnagar D. Diagnosis and screening for familial hypercholesterolaemia: finding the patients, finding the genes. Ann. Clin. Biochem. 43 (2006) 441-456
5. Jensen H.K., Jensen L.G., Meinertz H., Hansen P.S., Gregersen N., and Faergeman O. Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia. Atherosclerosis 146 (1999) 337-344
6. Sudhof T.C., Goldstein J.L., Brown M.S., and Russell D.W. The LDL receptor gene: a mosaic of exons shared with different proteins. Science 228 (1985) 815-822
7. The low density lipoprotein receptor (LDLR) gene in familial hypercholesterolemia. http://www.ucl.ac.uk/fh.
8. Fouchier S.W., Kastelein J.J., and Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Human Mutat 26 (2005) 550-556
9. Maruyama T., Yamashita S., Matsuzawa Y., Bujo H., Takahashi K., Saito Y., et al. Mutations in Japanese subjects with primary hyperlipidemia-results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb 11 (2004) 131-145
10. Sijbrands E.J.G., Westendorp R.G.J., Lombardi M.P., Havekes L.M., Frants R.R., Kastelein J.J., et al. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 149 (2000) 421-425
11. Abifadel M., Varret M., Rabes J.P., Allard D., Ouguerram K., Devillers M., et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34 (2003) 154-156
12. Zhao Z., Tuakli-Wosornu Y., Lagace T.A., Kinch L., Grishin N.V., Horton J.D., et al. Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote. Am J Hum Genet 79 (2006) 514-523
13. Williams R.R., Hamilton-Craig I., Kostner G.M., Hegele R.A., Hayden M.R., Pimstone S.N., et al. MED-PED: an integrated genetic strategy for preventing early deaths. In: Berg K., Boulyjenkov V., and Christen Y. (Eds). Genetic Approaches to Noncommunicable Diseases (1996), Springer-Verlag, Berlin, Heidelberg 35-45
14. Jansen A.C., van Aalst-Cohen E.S., Tanck M.W., Trip M.D., Lansberg P.J., Liem A.H., et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J Intern Med 256 (2004) 482-490
15. van Wissen S., Smilde T.J., Trip M.D., Stalenhoef A.F., and Kastelein J.J. Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. Am J Cardiol 95 (2005) 264-266
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Brusgaard K., Jordan P., Hansen H., Hansen A.B., and Horder M. Molecular genetic analysis of 1053 Danish individuals with clinical signs of Familial Hypercholesterolemia. Clin Genet 69 (2006) 277-283
18. Dedoussis G.V., Skoumas J., Pitsavos C., Choumerianou D.M., Genschel J., Schmidt H., et al. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations. Eur J Clin Investig 34 (2004) 402-409
19. Damgaard D., Larsen M.L., Nissen P.H., Jensen J.M., Jensen H.K., Soerensen V.R., et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 180 (2005) 155-160
20. Jansen A.C., van Aalst-Cohen E.S., Tanck M.W., Cheng S., Fontecha M.R., Li J., et al. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 25 (2005) 1475-1481
21. Neil H.A., Seagroatt V., Betteridge D.J., Cooper M.P., Durrington P.N., Miller J.P., et al. Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart 90 (2004) 1431-1437
22. Berge K.E., Ose L., and Leren T.P. Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy. Arterioscler Thromb Vasc Biol 26 (2006) 1094-1100
23. Pisciotta L., Priore Oliva C., Cefalu A.B., Noto D., Bellocchio A., Fresa R., et al. Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia. Atherosclerosis 186 (2006) 433-440
24. Bertolini S., Pisciotta L., Di Scala L., Langheim S., Bellocchio A., Masturzo P., et al. Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis 174 (2004) 57-65
25. Scientific Steering Committee on behalf of The Simon Broome Familial Hyperlipidaemia Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: Implications for patient management. Atherosclerosis 142 (1999) 105-112
26. Mendelsohn M.E., and Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science 308 (2005) 1583-1587
27. Damgaard D., and Faergeman O. Genotypes or phenotypes in cardiovascular diagnosis?. Eur Heart J 27 (2006) 2150-2151